The expression levels of PRR13 have been observed to vary in different types of cancer, including nasopharyngeal carcinoma, gastric cancer and non-small cell lung cancer, with its mRNA levels in tumour tissue serving as a reliable prognostic marker (Bai et al., 2010; Papadaki et al., 2009; Peng et al., 2010; Liu et al., 2023a). Here, PRR13 is linked to non-small cell lung carcinoma.